当前位置:首页 - 行情中心 - 南新制药(688189) - 财务分析 - 现金流量表

南新制药

(688189)

  

流通市值:24.09亿  总市值:24.09亿
流通股本:2.74亿   总股本:2.74亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金186,545,063.1164,459,677.19123,671,872.07306,289,354.29
  收到的税费返还204,856.6712,771.71-196,743.08
  收到其他与经营活动有关的现金18,955,390.1216,153,936.813,971,867.4713,345,941.5
  经营活动现金流入小计205,705,309.89180,626,385.7137,643,739.54319,832,038.87
  购买商品、接受劳务支付的现金26,146,015.5119,459,516.167,292,061.2872,676,854.47
  支付给职工以及为职工支付的现金41,088,371.9827,397,524.114,723,320.3475,969,327.79
  支付的各项税费8,022,938.735,846,837.492,383,950.2440,887,216.24
  支付其他与经营活动有关的现金55,224,920.1645,646,876.1213,906,302.83128,905,150.26
  经营活动现金流出小计130,482,246.3898,350,753.8738,305,634.69318,438,548.76
  经营活动产生的现金流量净额75,223,063.5182,275,631.8399,338,104.851,393,490.11
二、投资活动产生的现金流量:
  取得投资收益收到的现金---851,111.11
  处置固定资产、无形资产和其他长期资产收回的现金净额4,397,839.722,938,741.45-1,884,393.6
  收到的其他与投资活动有关的现金150,000,000--100,000,000
  投资活动现金流入的平衡项目00-0
  投资活动现金流入小计154,397,839.722,938,741.45-102,735,504.71
  购建固定资产、无形资产和其他长期资产支付的现金67,642,925.8963,872,061.338,982,772.2858,425,846.73
  支付其他与投资活动有关的现金150,000,000150,000,000150,000,000-
  投资活动现金流出小计217,642,925.89213,872,061.3188,982,772.2858,425,846.73
  投资活动产生的现金流量净额-63,245,086.17-210,933,319.85-188,982,772.2844,309,657.98
三、筹资活动产生的现金流量:
  取得借款收到的现金---119,000,000
  收到其他与筹资活动有关的现金---103,572,609.97
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---222,572,609.97
  偿还债务支付的现金70,000,00070,000,000-323,800,000
  分配股利、利润或偿付利息支付的现金2,210,266.65--5,226,482.99
  支付其他与筹资活动有关的现金7,374,877.662,227,871.66259,70410,708,383.16
  筹资活动现金流出小计79,585,144.3172,227,871.66259,704339,734,866.15
  筹资活动产生的现金流量净额-79,585,144.31-72,227,871.66-259,704-117,162,256.18
五、现金及现金等价物净增加额-67,607,166.97-200,885,559.68-89,904,371.43-71,459,108.09
  加:期初现金及现金等价物余额490,270,275.37490,270,275.37490,270,275.37561,729,383.46
  期末现金及现金等价物余额422,663,108.4289,384,715.69400,365,903.94490,270,275.37
补充资料:
  净利润--43,826,515.3--397,273,855.83
  资产减值准备-3,555,852.62-41,297,260.04
  固定资产和投资性房地产折旧-9,928,006.42-21,644,978.05
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-9,928,006.42-21,644,978.05
  无形资产摊销-8,160,979.78-15,818,025.69
  长期待摊费用摊销-19,025.39-712,458.91
  处置固定资产、无形资产和其他长期资产的损失----594,628.23
  财务费用-1,448,716.65-5,401,505.42
  投资损失-275,386.3--
  递延所得税--129,469.06-5,619,004.03
  其中:递延所得税资产减少--24,278.18-6,098,823.85
    递延所得税负债增加--105,190.88--479,819.82
  存货的减少-7,369,859.2--29,625,996.9
  经营性应收项目的减少-120,486,584.89-65,902,520.69
  经营性应付项目的增加--35,807,719.48--11,895,012.7
  现金的期末余额-289,384,715.69-490,270,275.37
  减:现金的期初余额-490,270,275.37-561,729,383.46
  现金及现金等价物的净增加额--200,885,559.68--71,459,108.09
公告日期2025-10-312025-08-292025-04-302025-04-30
审计意见(境内)标准无保留意见
TOP↑